Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Cipla
Fish and Richardson
US Army
Boehringer Ingelheim
Argus Health
Accenture
Mallinckrodt
QuintilesIMS
UBS

Generated: October 21, 2017

DrugPatentWatch Database Preview

ZOLADEX Drug Profile

« Back to Dashboard

Which patents cover Zoladex, and when can generic versions of Zoladex launch?

Zoladex is a drug marketed by Tersera Theraps Llc and is included in two NDAs. There are three patents protecting this drug.

This drug has fifty-one patent family members in thirty-three countries.

The generic ingredient in ZOLADEX is goserelin acetate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the goserelin acetate profile page.

Summary for Tradename: ZOLADEX

US Patents:3
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list16
Clinical Trials: see list99
Patent Applications: see list5,242
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZOLADEX at DailyMed

Pharmacology for Tradename: ZOLADEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes► Subscribe► SubscribeY ► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ZOLADEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION019726-001Dec 29, 1989► Subscribe► Subscribe
Tersera Theraps Llc
ZOLADEX
goserelin acetate
IMPLANT;IMPLANTATION020578-001Jan 11, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ZOLADEX

Country Document Number Estimated Expiration
Russian Federation2002124770► Subscribe
Bulgaria65506► Subscribe
Russian Federation2234341► Subscribe
Hong Kong1049454► Subscribe
Japan4208466► Subscribe
China1202875► Subscribe
Cyprus1107998► Subscribe
Poland357237► Subscribe
Iceland2464► Subscribe
Spain2273803► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Farmers Insurance
Harvard Business School
Cipla
Merck
Covington
Fuji
Cantor Fitzgerald
Cerilliant
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot